QF
SIOX

QVT Financial’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

QVT Financial’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-9,375,000
Closed -$395M – 65
2017
Q4 		$395M Hold
9,375,000
– – 22.3% 2
2017
Q3 		$516M Hold
9,375,000
– – 19.23% 2
2017
Q2 		$1.74B Hold
9,375,000
– – 46.44% 1
2017
Q1 		$1.12B Hold
9,375,000
– – 34.8% 1
2016
Q4 		$932M Hold
9,375,000
– – 28.29% 1
2016
Q3 		$1.05B Buy
+9,375,000
New +$1.13B 39.58% 1
2015
Q4 		– Sell
-9,375,000
Closed -$969M – 88
2015
Q3 		$969M Hold
9,375,000
– – 33.2% 1
2015
Q2 		$1.53B Buy
+9,375,000
New +$1.59B 23.12% 2

Other funds holding SIOX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

QVT Financial's SIOX Position: Q1 2018 in Review

QVT Financial sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2018, closing a stake of 9,375,000 shares — an estimated $395M sold.

QVT Financial first reported a position in SIOX in Q2 2015 and held it in 8 quarters. The position peaked at $1.74B in Q2 2017. 81 funds tracked by Wall St. Rank hold SIOX as of Q1 2018.

  • QVT Financial reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • QVT Financial sold 9,375,000 Sio Gene Therapies Inc. Common Stock shares in Q1 2018, an estimated $395M.
  • QVT Financial first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 8 quarters.
  • QVT Financial's Sio Gene Therapies Inc. Common Stock position peaked at $1.74B in Q2 2017.
  • 81 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2018.

Based on QVT Financial's 13F filing for Q1 2018, filed 15 May 2018.